Patents Assigned to TURNSTONE LIMITED PATNERSHIP
  • ONCOLYTIC RHABDOVIRUS
    Publication number: 20170165305
    Abstract: Embodiments of the invention include compositions and methods related to non-VSV rhabdoviruses and their use as anti-cancer therapeutics. Such rhabdoviruses possess tumor cell killing properties in vitro and in vivo.
    Type: Application
    Filed: February 17, 2017
    Publication date: June 15, 2017
    Applicant: TURNSTONE LIMITED PATNERSHIP
    Inventors: David F. STOJDL, John BELL